McKnight Brain Institute

MBI Director Todd Golde, M.D., Ph.D., looks back at 2018 – a year that marked 20 years since our institute opened its doors – and shares his excitement about the future.

Following the passing of actor Luke Perry due to stroke, Dr. Brian Hoh discusses the signs, risk factors and prevalence of stroke, and his hope for future research and care.

British physicians cycling for a cause visited the McKnight Brain Institute on the final leg of their attempt to tandem cycle the world in record time.

Alcohol and Drug Addiction: The Gain in the Brain is in the Pain.

More than 100 brain tumor experts united at the inaugural ReMission Summit in Orlando with a mission to rewrite the story of brain cancer through collaboration and innovation.

See media highlights stemming from Feb. 22's announcement of The Harris Rosen Foundation's gift to advance brain tumor immunotherapy research at the MBI and launch the ReMission Alliance Against Brain Tumors.

A team led by Cara Croft, Ph.D., has demonstrated a novel method to model Alzheimer’s disease and Parkinson’s disease pathologies and seek potential therapeutic targets. Learn more:

See media highlights stemming from Jan. 30's UF Health Florida Recovery Center expansion announcement.

Experts at the FRC partner with MBI researchers to develop the best multidisciplinary treatments for those battling substance use disorders.

A team of UF researchers were featured on the cover of the Journal of Biological Chemistry’s year in review edition, highlighting 2018’s most exciting and significant research.